
PF-06952229
CAS No. 1801333-55-0
PF-06952229( PF06952229 )
Catalog No. M26371 CAS No. 1801333-55-0
PF-06952229 is an selective and orally active inhibitor of TGFbR1.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 260 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
500MG | 2673 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePF-06952229
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06952229 is an selective and orally active inhibitor of TGFbR1.
-
DescriptionPF-06952229 is an selective and orally active inhibitor of TGFbR1.(In Vivo):In MCF-7 ER+ HER2-xenograft breast cancer tumor model, PF-06952229 (30 mg/kg; gavage) combines with Palbociclib results in an improved inhibition of pSMAD2 and a significant increase in survival.
-
In Vitro——
-
In VivoPF-06952229 (oral gavage; 30 mg/kg; twice daily; 21 days) combines with Palbociclib 21 days results in an improved inhibition of pSMAD2 in the MCF7 ER+?xenograft breast cancer tumor model. This combination also leads to a significant increase in survival relative to PF-06952229 monotherapy. Animal Model:MCF-7 ER+?HER2-xenograft breast cancer tumor modelDosage:30 mg/kg Administration:Oral gavage; twice daily; 44 days Result:Resulted in an increase in tumor growth inhibition when combined with Palbociclib.
-
SynonymsPF06952229
-
PathwayOthers
-
TargetOther Targets
-
RecptorMRP4| OAT1| OAT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801333-55-0
-
Formula Weight458.92
-
Molecular FormulaC23H24ClFN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (108.95 mM)
-
SMILESCC(C)c1cnc(cc1Nc1ccncc1C(=O)NC(CO)CO)-c1cc(Cl)ccc1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kamiński T, Micha?owska M, Pawlak D. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease. Postepy Hig Med Dosw (Online). 2017 Jul 30;71(0):624-632. Review.
molnova catalog



related products
-
Lophanthoidin F
Lophanthoidin F is a kind of natural product derived from the herbs of Rabdosia lophanthoides.
-
Diclofenac diethylam...
Diclofenac Diethylamine is a non-selective COX inhibitor used as a nonsteroidal anti-inflammatory drug (NSAID).
-
Atractylochromene
Atractylochromene is an inhibitor of β-catenin dependent Wnt pathway, it may be a potential chemotherapeutic agent for the prevention and treatment of human colon cancer.